Immunotherapy in Translational Cancer Research
Translational Oncology 1. Aufl.
Editors, vi Contributors, vii Introduction, ix 1 Translation in Immunology: The Role of Translational Biomarkers to Guide Clinical Use of Immunotherapy for Cancer, 1Saranya Chumsri and Keith L. Knutson 2 Monoclonal Antibody Therapy, 12Elizabeth A. Mittendorf and Sabitha Prabhakaran 3 Somatic Mutations and Immunotherapy, 24Eric Tran 4 Checkpoint Blockade, 37Tracy A. Proverbs?]Singh, Jedd Wolchok, and Alexandra Snyder 5 Myeloid Leukemia Vaccines, 54Paul M. Armistead and Jonathan S. Serody 6 Cancer Vaccines for Solid Tumors, 72Timothy J. Vreeland, Garth S. Herbert, and George E. Peoples 7 Immunotherapy with Non–Genetically Modified T Cells, 91Cassian Yee 8 Immunotherapy with Genetically Modified T Cells, 101Liora Schultz and Crystal Mackall 9 Immunomodulation with Adjuvants and Cytokines, 115Dae won Kim and Adi Diab 10 Immune Cell Migration in Cancer and Immunotherapy, 132Timothy Murray and Daniel E. Speiser 11 Repurposing of Drugs for Immunotherapy, 143Jyothishmathi Swaminathan and Vidya Gopalakrishnan 12 Immunomodulation with Radiation, 161Jonathan E. Schoenhals, Taylor R. Cushman, Alexandra P. Cadena, Sandra Demaria, and James W. Welsh 13 Good Manufacturing Practices Facilities for Cellular Therapy, 177Andrew D. Fesnak and Bruce L. Levine 14 T Cell Receptor Mimic Antibodies, 186Gheath Alatrash and Jeffrey J. Molldrem 15 Stem Cell Transplantation for Treatment of Malignancy, 201Lohith S. Bachegowda and Richard E. Champlin 16 Natural Killer Cell–Based Immunotherapy, 215Jennifer A. Foltz, Jeffrey S. Miller, and Dean A. Lee 17 Immunologic Monitoring in Immuno?] Oncology, 228William R. Gwin and Mary L. Disis 18 Cell?]Based Therapies for Canine Cancer, 252Nicola J. Mason and M. Kazim Panjwani 19 Interaction between Targeted Therapy and Immunotherapy, 268Peter A. Prieto, Miles C. Andrews, Alexandria P. Cogdill, and Jennifer A. Wargo Index 286
Laurence J. N. Cooper, Associate Professor, Department of Pediatrics, The University of Texas MD Anderson Cancer Center, Houston, USA. Elizabeth A. Mittendorf, Professor, Department of Breast Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, USA. Judy Moyes, Department of Pediatric Research, The University of Texas MD Anderson Cancer Center, Houston, USA. Sabitha Prabhakaran, Clinical Research Scientist, Department of Breast Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, USA.
A guide to state-of-the-art cancer immunotherapy in translational cancer research A volume in the Translational Oncology series, Immunotherapy in Translational Cancer Research explores the recent developments in the role that immunotherapy plays in the treatment of a wide range of cancers. The editors present key concepts, illustrative examples, and suggest alternative strategies in order to achieve individualized targeted therapy. Comprehensive in scope, Immunotherapy in Translational Cancer Research reviews the relevant history, current state, and the future of burgeoning cancer-fighting therapies. The book also includes critical information on drug development, clinical trials, and governmental resources and regulatory issues. Each chapter is created to feature: development of the immunotherapy; challenges that have been overcome in order to scale up and undertake clinical trials; and clinical experience and application of research. This authoritative volume is edited by a team of noted experts from MD Anderson Cancer Center, the world???s foremost cancer research and care center and: Offers a comprehensive presentation of state-of-the-art cancer immunotherapy research that accelerates the pace of clinical cancer care Filled with the concepts, examples, and approaches for developing individualized therapy Explores the breath of treatments that reflect the complexity of the immune system itself Includes contributions from a panel international experts in the field of immunotherapy Designed for physicians, medical students, scientists, pharmaceutical executives, public health and public policy government leaders and community oncologists, this essential resource offers a guide to the bidirectional interaction between laboratory and clinic immunotherapy cancer research
Diese Produkte könnten Sie auch interessieren:
NeuheitenA Companion to Literary Theory 35,99 €
Nursing Older People at a Glance 26,99 €
Annual Update for Accountants and A... 77,99 €
Statement of Cash Flows: Preparatio... 77,99 €
Electrochemical Engineering 108,99 €